Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine: Mere Coincidence or Something More?
Description
In this case report, we present a distinctive occurrence of classic Kaposi sarcoma (KS) in an individual of Latin origin, emerging seven days following the administration of the third dose of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. The progression
